Alaunos Therapeutics: Keep An Eye On Upcoming TCR-T Solid Tumor Study Data (NASDAQ:TCRT)
Alaunos has undergone a name change and a staff and management overhaul over the past 12 months.
Source: seekingalpha.com
Stay updated with breaking news from Holder Weis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alaunos has undergone a name change and a staff and management overhaul over the past 12 months.